You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康臣(01681.HK)漲16%曾破頂 大股東擬溢價售股引資萬邦德醫藥
康臣葯業(01681.HK)大股東擬溢價售股引資萬邦德醫藥(002082.SZ),該股今早高開15%報4.71元獲承接,曾突破52周高位5元,最多飆95%至8元創逾四年高遇阻,現報4.77元,漲16%,一向薄弱成交急增至948萬股,逾兩年來罕見,涉資4,731萬元。此外,萬邦德今天反覆高見11.83元人民幣,創近期新高,現報11.38元人民幣,續升2.5%。 康臣公布,控股股東中成發展、Double Grace以及黎倩(作為賣方)與萬邦德醫藥控股(潛在買方)訂立無法律約束力意向書(獨家權利至10月31日止)。據此,賣方潛在向買方出售合共2.38億股或佔公司股本29.5%持股;根據潛在買方對集團估值74億人民幣計算,每股暫定作價9.17元人民幣,折約10.64港元(較昨天收市價溢價達159.51%)。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account